Article
Current Challenges for IDO2 as Target in Cancer Immunotherapy
21 Apr 2021
Abstract excerpt
Immune checkpoint inhibitors have revolutionized the clinical approach of untreatable tumors and brought a breath of fresh air in cancer immunotherapy. However, the therapeutic effects of these drugs only cover a minority of patients and alternative immunotherapeutic targets are required. Metabolism of l-tryptophan (Trp) via the kynurenine pathway represents an important immune checkpoint mechanism that controls...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
